Sophocarpine monohydrate
(Synonyms: 槐果碱水合物) 目录号 : GC64223An alkaloid with diverse biological activities
Cas No.:145572-44-7
Sample solution is provided at 25 µL, 10mM.
Sophocarpine is an alkaloid that has been found in S. flavescens roots and has diverse biological activities.1,2,3,4,5 It is cytotoxic to HL-60, U937, K562, EC109, A549, and HepG2 cancer cells (IC50s = 1.64-12.86 mM).1 Sophocarpine is nematocidal against B. xylophilus in vitro.2 In vivo, sophocarpine (30 mg/kg) reduces infarct size, cardiac muscle fiber swelling and hypertrophy, and neutrophil infiltration in a rat model of myocardial ischemia and reperfusion injury.3 It decreases liver weight, fibrosis, and levels of IL-6, TNF-α, and TGF-β1 in a rat model of non-alcoholic steatohepatitis (NASH).4 Sophocarpine (15 and 30 mg/kg) reduces carrageenan-induced hind paw edema in rats and decreases acetic acid-induced writhing in mice.5
1.Lin, Z., Huang, C.-F., Liu, X.-S., et al.In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens AitBasic Clin. Pharmacol. Toxicol.108(5)304-309(2011) 2.Matsuda, K., Yamada, K., Kimura, M., et al.Nematicidal activity of matrine and its derivatives against pine wood nematodesJ. Agric. Food Chem.39(1)189-191(1991) 3.Li, C., Gao, Y., Tian, J., et al.Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivationJ. Ethnopharmacol.135(3)620-625(2011) 4.C.-Y., S., Zeng, X., Chen, S.-W., et al.Sophocarpine alleviates non-alcoholic steatohepatitis in ratsJ. Gastroenterol. Hepatol.26(4)765-774(2011) 5.Gao, Y., Li, G., Li, C., et al.Anti-nociceptive and anti-inflammatory activity of sophocarpineJ. Ethnopharmacol.125(2)324-329(2009)
Cas No. | 145572-44-7 | SDF | Download SDF |
别名 | 槐果碱水合物 | ||
分子式 | C15H24N2O2 | 分子量 | 264.36 |
溶解度 | DMSO : 100 mg/mL (378.27 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.7827 mL | 18.9136 mL | 37.8272 mL |
5 mM | 0.7565 mL | 3.7827 mL | 7.5654 mL |
10 mM | 0.3783 mL | 1.8914 mL | 3.7827 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet